EP
CAH icon

Eudaimonia Partners’s Cardinal Health CAH Stock Holding History

Eudaimonia Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,263
Closed -$214K – 332
2023
Q2 		$214K Buy
+2,263
New +$191K 0.05% 309
2023
Q1 		– Sell
-3,000
Closed -$231K – 357
2022
Q4 		$231K Sell
3,000
-4,823
-62% -$366K 0.06% 303
2022
Q3 		$522K Sell
7,823
-7,359
-48% -$466K 0.14% 162
2022
Q2 		$794K Buy
15,182
+8,244
+119% +$469K 0.15% 158
2022
Q1 		$393K Buy
+6,938
New +$372K 0.07% 274
2021
Q3 		– Sell
-3,618
Closed -$207K – 391
2021
Q2 		$207K Buy
3,618
+896
+33% +$52.4K 0.04% 367
2021
Q1 		$165K Buy
2,722
+500
+23% +$27.6K 0.03% 374
2020
Q4 		$119K Sell
2,222
-585
-21% -$30.4K 0.03% 407
2020
Q3 		$132K Sell
2,807
-5,680
-67% -$291K 0.03% 347
2020
Q2 		$443K Buy
8,487
+848
+11% +$43.7K 0.17% 137
2020
Q1 		$366K Buy
7,639
+4,894
+178% +$254K 0.16% 152
2019
Q4 		$139K Buy
+2,745
New +$142K 0.06% 293

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eudaimonia Partners's CAH Position: Q3 2023 in Review

Eudaimonia Partners sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 2,263 shares — an estimated $214K sold.

Eudaimonia Partners first reported a position in CAH in Q4 2019 and held it in 12 quarters. The position peaked at $794K in Q2 2022. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Eudaimonia Partners reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 2,263 Cardinal Health shares in Q3 2023, an estimated $214K.
  • Eudaimonia Partners first reported a position in Cardinal Health in Q4 2019 and held it in 12 quarters.
  • Eudaimonia Partners's Cardinal Health position peaked at $794K in Q2 2022.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Eudaimonia Partners's 13F filing for Q3 2023, filed 24 Oct 2023.